Most Read Articles
01 Oct 2015
BLACKMORES ESSENTIAL LIVO – Phosphatidylcholine, Zinc and Chromium Capsules
Jackey Suen, 07 Jul 2017

The experimental drug ABT-981 fails to show significant improvements in pain and joint symptoms compared with placebo in patients with hand osteoarthritis (OA), according to a phase IIa trial presented at the European League Against Rheumatism (EULAR) Annual Congress 2017 held in Madrid, Spain. 

13 Dec 2016
Any abnormal decrease in a person’s usual bowel movement frequency and/or pain during stool passage is termed as Constipation.
Roshini Claire Anthony, 08 Nov 2017

The presence of vitreous haze, snow banking, and choroidal involvement is associated with an increased risk of antitubercular treatment failure in patients with tubercular (TB) uveitis, according to research by the COTS-1* Study Group.

Do proton pump inhibitors promote development of dementia?

24 Aug 2017

Use of proton pump inhibitors (PPIs) does not appear to have any effect on cognitive function, with a recent study suggesting that the drugs do not increase the risk of dementia.

Researchers examined data on medication use and other potential risk factors from 13,864 participants in the Nurses’ Health Study II. All participants completed a self-administered computerized neuropsychological test battery.

Multivariable linear regression analysis found a modest association between duration of PPI use and scores for psychomotor speed and attention. The mean score difference for PPI use of 9 to 14 years vs nonuse was –0.06 (95 percent CI, –0.11 to 0.00; p=0.03 for trend). However, the magnitude of this score difference shrank after adjusting for the use of H2 receptor antagonists (H2RAs).

Among individuals who were not regular PPI users, duration of H2RA use was associated with poor cognitive scores, and this relationship was most pronounced for learning and working memory (mean score difference for H2RA users of 9 to 14 years vs nonusers, –0.20; –0.32 to –0.08; p<0.001 for trend).

The present data do not support the suggestion that PPI use increases dementia risk, researchers said, adding that findings for H2RAs should be interpreted with caution as the primary hypothesis was related to PPI use.

While the underlying mechanism by which PPIs might influence the development of dementia is unclear, there are pieces of evidence linking PPI use to cognitive decline. Several studies have shown that some PPIs (eg, lansoprazole and omeprazole) could cross the blood-brain barrier and directly affect the brain. The drugs are also said to be capable of interacting with brain enzymes, as well as inducing increased amyloid beta levels in an amyloid cell model and in the brains of mice. [PLoS One 2013;8:e58837; J Chromatogr A 2002;949:35-42; J Alzheimers Dis 2010;19:573-589]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 Oct 2015
BLACKMORES ESSENTIAL LIVO – Phosphatidylcholine, Zinc and Chromium Capsules
Jackey Suen, 07 Jul 2017

The experimental drug ABT-981 fails to show significant improvements in pain and joint symptoms compared with placebo in patients with hand osteoarthritis (OA), according to a phase IIa trial presented at the European League Against Rheumatism (EULAR) Annual Congress 2017 held in Madrid, Spain. 

13 Dec 2016
Any abnormal decrease in a person’s usual bowel movement frequency and/or pain during stool passage is termed as Constipation.
Roshini Claire Anthony, 08 Nov 2017

The presence of vitreous haze, snow banking, and choroidal involvement is associated with an increased risk of antitubercular treatment failure in patients with tubercular (TB) uveitis, according to research by the COTS-1* Study Group.